Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Marc Ladanyi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Procedures
Disorders
Physiology
Concepts & Ideas
Phenomena
Sign-in to see full Profile
Network (preview)
29
Antonescu, Cristina
26
Healey, John
21
Argani, Pedram
19
Pao, William
18
Jhanwar, Suresh
17
Zakowski, Maureen
15
Chaganti, Raju
15
Huvos, Andrew
14
Kris, Mark
12
Meyers, Paul
11
Miller, Vincent
11
Riely, Gregory
11
Filippa, Daniel
11
Gorlick, Richard
10
Gerald, William
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Marc Ladanyi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Girard Nicolas; Shen Ronglai; Guo Tianhua; Zakowski Maureen F; Heguy Adriana; Riely Gregory J; Huang James; Lau Christopher; Lash Alex E; Ladanyi Marc; Viale Agnes; Antonescu Cristina R; Travis William D; Rusch Valerie W; Kris Mark G; Pao William
Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):6790-9.
-
2009: Shen Ronglai; Olshen Adam B; Ladanyi Marc
Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis.
Bioinformatics (Oxford, England) 2009;25(22):2906-12.
-
2009: Pao William; Kris Mark G; Iafrate A John; Ladanyi Marc; Jänne Pasi A; Wistuba Ignacio I; Miake-Lye Ryn; Herbst Roy S; Carbone David P; Johnson Bruce E; Lynch Thomas J
Integration of molecular profiling into the lung cancer clinic.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(17):5317-22.
-
2009: Girard Nicolas; Ostrovnaya Irina; Lau Christopher; Park Bernard; Ladanyi Marc; Finley David; Deshpande Charuhas; Rusch Valerie; Orlow Irene; Travis William D; Pao William; Begg Colin B
Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5184-90.
-
2009: Chitale D; Gong Y; Taylor B S; Broderick S; Brennan C; Somwar R; Golas B; Wang L; Motoi N; Szoke J; Reinersman J M; Major J; Sander C; Seshan V E; Zakowski M F; Rusch V; Pao W; Gerald W; Ladanyi M
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
Oncogene 2009;28(31):2773-83.
-
2009: Nguyen Don X; Chiang Anne C; Zhang Xiang H-F; Kim Juliet Y; Kris Mark G; Ladanyi Marc; Gerald William L; Massagué Joan
WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
Cell 2009;138(1):51-62.
-
2009: Ricarte-Filho Julio C; Ryder Mabel; Chitale Dhananjay A; Rivera Michael; Heguy Adriana; Ladanyi Marc; Janakiraman Manickam; Solit David; Knauf Jeffrey A; Tuttle R Michael; Ghossein Ronald A; Fagin James A
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
Cancer research 2009;69(11):4885-93.
-
2009: Veeriah Selvaraju; Brennan Cameron; Meng Shasha; Singh Bhuvanesh; Fagin James A; Solit David B; Paty Philip B; Rohle Dan; Vivanco Igor; Chmielecki Juliann; Pao William; Ladanyi Marc; Gerald William L; Liau Linda; Cloughesy Timothy C; Mischel Paul S; Sander Chris; Taylor Barry; Schultz Nikolaus; Major John; Heguy Adriana; Fang Fang; Mellinghoff Ingo K; Chan Timothy A
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(23):9435-40.
-
2009: Kimura Taichi; Sakai Mieko; Tabu Kouichi; Wang Lei; Tsunematsu Ryosuke; Tsuda Masumi; Sawa Hirofumi; Nagashima Kazuo; Nishihara Hiroshi; Hatakeyama Shigetsugu; Nakayama Keiko; Ladanyi Marc; Tanaka Shinya; Nakayama Keiichi I
Human synovial sarcoma proto-oncogene Syt is essential for early embryonic development through the regulation of cell migration.
Laboratory investigation; a journal of technical methods and pathology 2009;89(6):645-56.
-
2009: Nishijo Koichi; Chen Qing-Rong; Zhang Lei; McCleish Amanda T; Rodriguez Andrea; Cho Min Jung; Prajapati Suresh I; Gelfond Jonathan A L; Chisholm Gary B; Michalek Joel E; Aronow Bruce J; Barr Frederic G; Randall R Lor; Ladanyi Marc; Qualman Stephen J; Rubin Brian P; LeGallo Robin D; Wang Chiayeng; Khan Javed; Keller Charles
Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma.
Cancer research 2009;69(7):2902-11.
-
2009: Argani Pedram; Aulmann Sebastian; Karanjawala Zarir; Fraser Robert B; Ladanyi Marc; Rodriguez Maria M
Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
The American journal of surgical pathology 2009;33(4):609-19.
-
2009: Zakowski Maureen F; Hussain Sanaa; Pao William; Ladanyi Marc; Ginsberg Michelle S; Heelan Robert; Miller Vincent A; Rusch Valerie W; Kris Mark G
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.
Archives of pathology & laboratory medicine 2009;133(3):470-7.
-
2009: Ladanyi Marc
William L Gerald, M. D., Ph.D., 1954-2008.
The Journal of molecular diagnostics : JMD 2009;11(1):1-3.
-
2009: Filion C; Motoi T; Olshen A B; Laé M; Emnett R J; Gutmann D H; Perry A; Ladanyi M; Labelle Y
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
The Journal of pathology 2009;217(1):83-93.
-
2009: Gong Yixuan; Yao Evelyn; Shen Ronglai; Goel Aviva; Arcila Maria; Teruya-Feldstein Julie; Zakowski Maureen F; Frankel Stanley; Peifer Martin; Thomas Roman K; Ladanyi Marc; Pao William
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507).
PloS one 2009;4(10):e7273.
-
2008: Canter Robert J; Qin Li-Xuan; Maki Robert G; Brennan Murray F; Ladanyi Marc; Singer Samuel
A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(24):8191-7.
-
2008: Garcia Joaquin; Riely Gregory J; Nafa Khedoudja; Ladanyi Marc
KRAS mutational testing in the selection of patients for EGFR-targeted therapies.
Seminars in diagnostic pathology 2008;25(4):288-94.
-
2008: Pratilas Christine A; Hanrahan Aphrothiti J; Halilovic Ensar; Persaud Yogindra; Soh Junichi; Chitale Dhananjay; Shigematsu Hisayuki; Yamamoto Hiromasa; Sawai Ayana; Janakiraman Manickam; Taylor Barry S; Pao William; Toyooka Shinichi; Ladanyi Marc; Gazdar Adi; Rosen Neal; Solit David B
Genetic predictors of MEK dependence in non-small cell lung cancer.
Cancer research 2008;68(22):9375-83.
-
2008: Bean James; Riely Gregory J; Balak Marissa; Marks Jenifer L; Ladanyi Marc; Miller Vincent A; Pao William
Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7519-25.
-
2008: Sobel Mark E; Bagg Adam; Caliendo Angela M; Ladanyi Marc; Zehnbauer Barbara
The evolution of molecular genetic pathology: advancing 20th-century diagnostic methods into potent tools for the new millennium.
The Journal of molecular diagnostics : JMD 2008;10(6):480-3.
-
2008: Riely Gregory J; Ladanyi Marc
KRAS mutations: an old oncogene becomes a new predictive biomarker.
The Journal of molecular diagnostics : JMD 2008;10(6):493-5.
-
2008: Ding Li; Getz Gad; Wheeler David A; Mardis Elaine R; McLellan Michael D; Cibulskis Kristian; Sougnez Carrie; Greulich Heidi; Muzny Donna M; Morgan Margaret B; Fulton Lucinda; Fulton Robert S; Zhang Qunyuan; Wendl Michael C; Lawrence Michael S; Larson David E; Chen Ken; Dooling David J; Sabo Aniko; Hawes Alicia C; Shen Hua; Jhangiani Shalini N; Lewis Lora R; Hall Otis; Zhu Yiming; Mathew Tittu; Ren Yanru; Yao Jiqiang; Scherer Steven E; Clerc Kerstin; Metcalf Ginger A; Ng Brian; Milosavljevic Aleksandar; Gonzalez-Garay Manuel L; Osborne John R; Meyer Rick; Shi Xiaoqi; Tang Yuzhu; Koboldt Daniel C; Lin Ling; Abbott Rachel; Miner Tracie L; Pohl Craig; Fewell Ginger; Haipek Carrie; Schmidt Heather; Dunford-Shore Brian H; Kraja Aldi; Crosby Seth D; Sawyer Christopher S; Vickery Tammi; Sander Sacha; Robinson Jody; Winckler Wendy; Baldwin Jennifer; Chirieac Lucian R; Dutt Amit; Fennell Tim; Hanna Megan; Johnson Bruce E; Onofrio Robert C; Thomas Roman K; Tonon Giovanni; Weir Barbara A; Zhao Xiaojun; Ziaugra Liuda; Zody Michael C; Giordano Thomas; Orringer Mark B; Roth Jack A; Spitz Margaret R; Wistuba Ignacio I; Ozenberger Bradley; Good Peter J; Chang Andrew C; Beer David G; Watson Mark A; Ladanyi Marc; Broderick Stephen; Yoshizawa Akihiko; Travis William D; Pao William; Province Michael A; Weinstock George M; Varmus Harold E; Gabriel Stacey B; Lander Eric S; Gibbs Richard A; Meyerson Matthew; Wilson Richard K
Somatic mutations affect key pathways in lung adenocarcinoma.
Nature 2008;455(7216):1069-75.
-
2008: Riely Gregory J; Kris Mark G; Rosenbaum Daniel; Marks Jenifer; Li Allan; Chitale Dhananjay A; Nafa Khedoudja; Riedel Elyn R; Hsu Meier; Pao William; Miller Vincent A; Ladanyi Marc
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5731-4.
-
2008: Marks Jenifer L; Gong Yixuan; Chitale Dhananjay; Golas Ben; McLellan Michael D; Kasai Yumi; Ding Li; Mardis Elaine R; Wilson Richard K; Solit David; Levine Ross; Michel Kathrin; Thomas Roman K; Rusch Valerie W; Ladanyi Marc; Pao William
Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.
Cancer research 2008;68(14):5524-8.
-
2008: Lu Xin-Yan; Lu Yaojuan; Zhao Yi-Jue; Jaeweon Kim; Kang Jason; Xiao-Nan Li; Ge Gouqing; Meyer Rene; Perlaky Laszlo; Hicks John; Chintagumpala Murali; Cai Wei-Wen; Ladanyi Marc; Gorlick Richard; Lau Ching C; Pati Debananda; Sheldon Michael; Rao Pulivarthi H
Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.
Molecular cancer research : MCR 2008;6(6):937-46.
-
2008: Mercado Gabriela E; Xia Shujuan J; Zhang Chune; Ahn Eun Hyun; Gustafson Donna M; Laé Marick; Ladanyi Marc; Barr Frederic G
Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target.
Genes, chromosomes & cancer 2008;47(6):510-20.
-
2008: Ladanyi Marc; Pao William
Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21 Suppl 2():S16-22.
-
2008: Ladanyi Marc
Targeted therapy of cancer: new roles for pathologists.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21 Suppl 2():S1.
-
2008: Li Allan R; Chitale Dhananjay; Riely Gregory J; Pao William; Miller Vincent A; Zakowski Maureen F; Rusch Valerie; Kris Mark G; Ladanyi Marc
EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.
The Journal of molecular diagnostics : JMD 2008;10(3):242-8.
-
2008: Wu Julie M; Fackler Mary Jo; Halushka Marc K; Molavi Diana W; Taylor M Evangeline; Teo Wei Wen; Griffin Constance; Fetting John; Davidson Nancy E; De Marzo Angelo M; Hicks Jessica L; Chitale Dhananjay; Ladanyi Marc; Sukumar Saraswati; Argani Pedram
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):1938-46.
-
2008: Miller Vincent A; Riely Gregory J; Zakowski Maureen F; Li Allan R; Patel Jyoti D; Heelan Robert T; Kris Mark G; Sandler Alan B; Carbone David P; Tsao Anne; Herbst Roy S; Heller Glenn; Ladanyi Marc; Pao William; Johnson David H
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1472-8.
-
2008: Marks Jenifer L; Broderick Stephen; Zhou Qin; Chitale Dhananjay; Li Allan R; Zakowski Maureen F; Kris Mark G; Rusch Valerie W; Azzoli Christopher G; Seshan Venkatraman E; Ladanyi Marc; Pao William
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):111-6.
-
2008: Taylor Barry S; Barretina Jordi; Socci Nicholas D; Decarolis Penelope; Ladanyi Marc; Meyerson Matthew; Singer Samuel; Sander Chris
Functional copy-number alterations in cancer.
PloS one 2008;3(9):e3179.
-
2007: Bean James; Brennan Cameron; Shih Jin-Yuan; Riely Gregory; Viale Agnes; Wang Lu; Chitale Dhananjay; Motoi Noriko; Szoke Janos; Broderick Stephen; Balak Marissa; Chang Wen-Cheng; Yu Chong-Jen; Gazdar Adi; Pass Harvey; Rusch Valerie; Gerald William; Huang Shiu-Feng; Yang Pan-Chyr; Miller Vincent; Ladanyi Marc; Yang Chih-Hsin; Pao William
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(52):20932-7.
-
2007: Cheung Irene Y; Feng Yi; Danis Karen; Shukla Neerav; Meyers Paul; Ladanyi Marc; Cheung Nai-Kong V
Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6978-83.
-
2007: Weir Barbara A; Woo Michele S; Getz Gad; Perner Sven; Ding Li; Beroukhim Rameen; Lin William M; Province Michael A; Kraja Aldi; Johnson Laura A; Shah Kinjal; Sato Mitsuo; Thomas Roman K; Barletta Justine A; Borecki Ingrid B; Broderick Stephen; Chang Andrew C; Chiang Derek Y; Chirieac Lucian R; Cho Jeonghee; Fujii Yoshitaka; Gazdar Adi F; Giordano Thomas; Greulich Heidi; Hanna Megan; Johnson Bruce E; Kris Mark G; Lash Alex; Lin Ling; Lindeman Neal; Mardis Elaine R; McPherson John D; Minna John D; Morgan Margaret B; Nadel Mark; Orringer Mark B; Osborne John R; Ozenberger Brad; Ramos Alex H; Robinson James; Roth Jack A; Rusch Valerie; Sasaki Hidefumi; Shepherd Frances; Sougnez Carrie; Spitz Margaret R; Tsao Ming-Sound; Twomey David; Verhaak Roel G W; Weinstock George M; Wheeler David A; Winckler Wendy; Yoshizawa Akihiko; Yu Soyoung; Zakowski Maureen F; Zhang Qunyuan; Beer David G; Wistuba Ignacio I; Watson Mark A; Garraway Levi A; Ladanyi Marc; Travis William D; Pao William; Rubin Mark A; Gabriel Stacey B; Gibbs Richard A; Varmus Harold E; Wilson Richard K; Lander Eric S; Meyerson Matthew
Characterizing the cancer genome in lung adenocarcinoma.
Nature 2007;450(7171):893-8.
-
2007: Antonescu Cristina R; Dal Cin Paola; Nafa Khedoudja; Teot Lisa A; Surti Urvashi; Fletcher Christopher D; Ladanyi Marc
EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.
Genes, chromosomes & cancer 2007;46(12):1051-60.
-
2007: Pao William; Ladanyi Marc
Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):4954-5.
-
2007: Wang Lu; Bhargava Rohit; Zheng Tao; Wexler Leonard; Collins Margaret H; Roulston Diane; Ladanyi Marc
Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions.
The Journal of molecular diagnostics : JMD 2007;9(4):498-509.
-
2007: Barbashina Violetta; Salazar Paulo; Ladanyi Marc; Rosenblum Marc K; Edgar Mark A
Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.
The American journal of surgical pathology 2007;31(8):1196-202.
-
2007: Argani Pedram; Olgac Semra; Tickoo Satish K; Goldfischer Michael; Moch Holger; Chan David Y; Eble John N; Bonsib Stephen M; Jimeno Mireya; Lloreta Josep; Billis Athanase; Hicks Jessica; De Marzo Angelo M; Reuter Victor E; Ladanyi Marc
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
The American journal of surgical pathology 2007;31(8):1149-60.
-
2007: Laé M; Ahn E H; Mercado G E; Chuai S; Edgar M; Pawel B R; Olshen A; Barr F G; Ladanyi M
Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
The Journal of pathology 2007;212(2):143-51.
-
2007: Tsuda Masumi; Davis Ian J; Argani Pedram; Shukla Neerav; McGill Gael G; Nagai Makoto; Saito Tsuyoshi; Laé Marick; Fisher David E; Ladanyi Marc
TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.
Cancer research 2007;67(3):919-29.
-
2007: Terry Jefferson; Saito Tsuyoshi; Subramanian Subbaya; Ruttan Cindy; Antonescu Cristina R; Goldblum John R; Downs-Kelly Erinn; Corless Christopher L; Rubin Brian P; van de Rijn Matt; Ladanyi Marc; Nielsen Torsten O
TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
The American journal of surgical pathology 2007;31(2):240-6.
-
2006: Balak Marissa N; Gong Yixuan; Riely Gregory J; Somwar Romel; Li Allan R; Zakowski Maureen F; Chiang Anne; Yang Guangli; Ouerfelli Ouathek; Kris Mark G; Ladanyi Marc; Miller Vincent A; Pao William
Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6494-501.
-
2006: Antonescu Cristina R; Nafa Khedoudja; Segal Neil H; Dal Cin Paola; Ladanyi Marc
EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5356-62.
-
2006: Saito Tsuyoshi; Nagai Makoto; Ladanyi Marc
SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma.
Cancer research 2006;66(14):6919-27.
-
2006: Zakowski Maureen F; Ladanyi Marc; Kris Mark G;
EGFR mutations in small-cell lung cancers in patients who have never smoked.
The New England journal of medicine 2006;355(2):213-5.
-
2006: Poulin Hugo; Filion Christine; Ladanyi Marc; Labelle Yves
Serum- and glucocorticoid-regulated kinase 1 (SGK1) induction by the EWS/NOR1(NR4A3) fusion protein.
Biochemical and biophysical research communications 2006;346(1):306-13.
-
2006: Argani Pedram; Laé Marick; Ballard Edgar T; Amin Mahul; Manivel Carlos; Hutchinson Brian; Reuter Victor E; Ladanyi Marc
Translocation carcinomas of the kidney after chemotherapy in childhood.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1529-34.
-
2006: Pham DuyKhanh; Kris Mark G; Riely Gregory J; Sarkaria Inderpal S; McDonough Tiffani; Chuai Shaokun; Venkatraman Ennapadam S; Miller Vincent A; Ladanyi Marc; Pao William; Wilson Richard K; Singh Bhuvanesh; Rusch Valerie W
Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(11):1700-4.
-
2006: López-Ríos Fernando; Chuai Shannon; Flores Raja; Shimizu Shigeki; Ohno Takatoshi; Wakahara Kazuhiko; Illei Peter B; Hussain Sanaa; Krug Lee; Zakowski Maureen F; Rusch Valerie; Olshen Adam B; Ladanyi Marc
Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
Cancer research 2006;66(6):2970-9.
-
2006: Arocho Alaina; Chen Beiyun; Ladanyi Marc; Pan Qiulu
Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2006;15(1):56-61.
-
2006: Riely Gregory J; Pao William; Pham Duykhanh; Li Allan R; Rizvi Naiyer; Venkatraman Ennapadam S; Zakowski Maureen F; Kris Mark G; Ladanyi Marc; Miller Vincent A
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):839-44.
-
2006: López-Ríos Fernando; Ladanyi Marc
Malignant mesothelioma.
The New England journal of medicine 2006;354(3):305-7; author reply 305-7.
-
2005: Pao William; Ladanyi Marc; Miller Vincent A;
Erlotinib in lung cancer.
The New England journal of medicine 2005;353(16):1739-41; author reply 1739-41.
-
2005: Huang Hsuan-Ying; Lui Man Yee; Ladanyi Marc
Nonrandom cell-cycle timing of a somatic chromosomal translocation: The t(X;17) of alveolar soft-part sarcoma occurs in G2.
Genes, chromosomes & cancer 2005;44(2):170-6.
-
2005: Pan Qiulu; Pao William; Ladanyi Marc
Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas.
The Journal of molecular diagnostics : JMD 2005;7(3):396-403.
-
2005: Ladanyi M
Translating research into cancer molecular diagnostics and patents.
Journal of clinical pathology 2005;58(8):793-4.
-
2005: Bhargava Rohit; Gerald William L; Li Allan R; Pan Qiulu; Lal Priti; Ladanyi Marc; Chen Beiyun
EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(8):1027-33.
-
2005: Ladanyi Marc
Implications of P16/CDKN2A deletion in pleural mesotheliomas.
Lung cancer (Amsterdam, Netherlands) 2005;49 Suppl 1():S95-8.
-
2005: Argani Pedram; Ladanyi Marc
Translocation carcinomas of the kidney.
Clinics in laboratory medicine 2005;25(2):363-78.
-
2005: Ladanyi Marc
Correlates of SYT-SSX fusion type in synovial sarcoma: getting more complex but also more interesting?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3638-9; author reply 3639-40.
-
2005: Barbashina Violetta; Salazar Paulo; Holland Eric C; Rosenblum Marc K; Ladanyi Marc
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1119-28.
-
2005: Argani Pedram; Laé Marick; Hutchinson Brian; Reuter Victor E; Collins Margaret H; Perentesis John; Tomaszewski John E; Brooks John S J; Acs Geza; Bridge Julia A; Vargas Sara O; Davis Ian J; Fisher David E; Ladanyi Marc
Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.
The American journal of surgical pathology 2005;29(2):230-40.
-
2005: Pao William; Wang Theresa Y; Riely Gregory J; Miller Vincent A; Pan Qiulu; Ladanyi Marc; Zakowski Maureen F; Heelan Robert T; Kris Mark G; Varmus Harold E
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.
PLoS medicine 2005;2(1):e17.
-
2005: Huang Hsuan-Ying; Illei Peter B; Zhao Zhiquan; Mazumdar Madhu; Huvos Andrew G; Healey John H; Wexler Leonard H; Gorlick Richard; Meyers Paul; Ladanyi Marc
Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):548-58.
-
2004: Saito Tsuyoshi; Oda Yoshinao; Kawaguchi Ken-ichi; Sugimachi Keishi; Yamamoto Hidetaka; Tateishi Naomi; Tanaka Kazuhiro; Matsuda Shuichi; Iwamoto Yukihide; Ladanyi Marc; Tsuneyoshi Masazumi
E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma.
Oncogene 2004;23(53):8629-38.
-
2004: Chen Wenyong; Cooper Timothy K; Zahnow Cynthia A; Overholtzer Michael; Zhao Zhiquan; Ladanyi Marc; Karp Judith E; Gokgoz Nalan; Wunder Jay S; Andrulis Irene L; Levine Arnold J; Mankowski Joseph L; Baylin Stephen B
Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
Cancer cell 2004;6(4):387-98.
-
2004: Yu Shun Jiang; Zheng Lei; Ladanyi Marc; Asa Sylvia L; Ezzat Shereen
Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6750-8.
-
2004: Ulaner Gary A; Hoffman Andrew R; Otero Jesse; Huang Hsuan-Ying; Zhao Zhiquan; Mazumdar Madhu; Gorlick Richard; Meyers Paul; Healey John H; Ladanyi Marc
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Genes, chromosomes & cancer 2004;41(2):155-62.
-
2004: López-Ríos Fernando; Illei Peter B; Rusch Valerie; Ladanyi Marc
Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids.
Lancet 2004;364(9440):1157-66.
-
2004: Bruder Elisabeth; Passera Oliver; Harms Dieter; Leuschner Ivo; Ladanyi Marc; Argani Pedram; Eble John N; Struckmann Kirsten; Schraml Peter; Moch Holger
Morphologic and molecular characterization of renal cell carcinoma in children and young adults.
The American journal of surgical pathology 2004;28(9):1117-32.
-
2004: Man Tsz-Kwong; Lu Xin-Yan; Jaeweon Kim; Perlaky Laszlo; Harris Charles P; Shah Shishir; Ladanyi Marc; Gorlick Richard; Lau Ching C; Rao Pulivarthi H
Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
BMC cancer 2004;4():45.
-
2004: Lal Priti; Salazar Paulo A; Hudis Clifford A; Ladanyi Marc; Chen Beiyun
HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring.
American journal of clinical pathology 2004;121(5):631-6.
-
2004: Huang Hsuan-Ying; Ladanyi Marc; Soslow Robert A
Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity.
The American journal of surgical pathology 2004;28(2):224-32.
-
2003: Kolb E Anders; Pan Qiulu; Ladanyi Marc; Steinherz Peter G
Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood.
Cancer 2003;98(12):2643-50.
-
2003: Argani Pedram; Ladanyi Marc
Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas.
Pathology 2003;35(6):492-8.
-
2003: Gorlick Richard; Anderson Peter; Andrulis Irene; Arndt Carola; Beardsley G Peter; Bernstein Mark; Bridge Julia; Cheung Nai-Kong; Dome Jeffrey S; Ebb David; Gardner Thomas; Gebhardt Mark; Grier Holcombe; Hansen Marc; Healey John; Helman Lee; Hock Janet; Houghton Janet; Houghton Peter; Huvos Andrew; Khanna Chand; Kieran Mark; Kleinerman Eugenie; Ladanyi Marc; Lau Ching; Malkin David; Marina Neyssa; Meltzer Paul; Meyers Paul; Schofield Deborah; Schwartz Cindy; Smith Malcolm A; Toretsky Jeffrey; Tsokos Maria; Wexler Leonard; Wigginton Jon; Withrow Stephen; Schoenfeldt Mason; Anderson Barry
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5442-53.
-
2003: Argani Pedram; Ladanyi Marc
Recent advances in pediatric renal neoplasia.
Advances in anatomic pathology 2003;10(5):243-60.
-
2003: Overholtzer Michael; Rao Pulivarthi H; Favis Reyna; Lu Xin-Yan; Elowitz Michael B; Barany Francis; Ladanyi Marc; Gorlick Richard; Levine Arnold J
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11547-52.
-
2003: Antonescu Cristina R; Sommer Gunhild; Sarran Lisa; Tschernyavsky Sylvia J; Riedel Elyn; Woodruff James M; Robson Mark; Maki Robert; Brennan Murray F; Ladanyi Marc; DeMatteo Ronald P; Besmer Peter
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3329-37.
-
2003: Argani Pedram; Lui Man Yee; Couturier Jérôme; Bouvier Raymonde; Fournet Jean-Christophe; Ladanyi Marc
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
Oncogene 2003;22(34):5374-8.
-
2003: Lal Priti; Salazar Paulo A; Ladanyi Marc; Chen Beiyun
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification.
The Journal of molecular diagnostics : JMD 2003;5(3):155-9.
-
2003: Illei Peter B; Rusch Valerie W; Zakowski Maureen F; Ladanyi Marc
Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2108-13.
-
2003: Borden Ernest C; Baker Laurence H; Bell Robert S; Bramwell Vivien; Demetri George D; Eisenberg Burton L; Fletcher Christopher D M; Fletcher Jonathan A; Ladanyi Marc; Meltzer Paul; O'Sullivan Brian; Parkinson David R; Pisters Peter W T; Saxman Scott; Singer Samuel; Sundaram Murali; van Oosterom Allan T; Verweij Jaap; Waalen Jill; Weiss Sharon W; Brennan Murray F
Soft tissue sarcomas of adults: state of the translational science.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):1941-56.
-
2003: Argani Pedram; Lal Priti; Hutchinson Brian; Lui Man Yee; Reuter Victor E; Ladanyi Marc
Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
The American journal of surgical pathology 2003;27(6):750-61.
-
2003: Davis Ian J; Hsi Bae-Li; Arroyo Jason D; Vargas Sara O; Yeh Y Albert; Motyckova Gabriela; Valencia Patricia; Perez-Atayde Antonio R; Argani Pedram; Ladanyi Marc; Fletcher Jonathan A; Fisher David E
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(10):6051-6.
-
2003: Ulaner Gary A; Huang Hsuan-Ying; Otero Jesse; Zhao Zhiquan; Ben-Porat Leah; Satagopan Jaya M; Gorlick Richard; Meyers Paul; Healey John H; Huvos Andrew G; Hoffman Andrew R; Ladanyi Marc
Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Cancer research 2003;63(8):1759-63.
-
2003: Uren A; Merchant M S; Sun C J; Vitolo M I; Sun Y; Tsokos M; Illei P B; Ladanyi M; Passaniti A; Mackall C; Toretsky J A
Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Oncogene 2003;22(15):2334-42.
-
2003: Ladanyi Marc
Translocation-based molecular diagnosis of sarcomas.
The American journal of surgical pathology 2003;27(3):414-5; author reply 415-6.
-
2003: Ulaner Gary A; Vu Thanh H; Li Tao; Hu Ji-Fan; Yao Xiao-Ming; Yang Youwen; Gorlick Richard; Meyers Paul; Healey John; Ladanyi Marc; Hoffman Andrew R
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
Human molecular genetics 2003;12(5):535-49.
-
2003: Illei Peter B; Ladanyi Marc; Rusch Valerie W; Zakowski Maureen F
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Cancer 2003;99(1):51-6.
-
2003: Laflamme Cynthia; Filion Christine; Bridge Julia A; Ladanyi Marc; Goldring Mary B; Labelle Yves
The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
Cancer research 2003;63(2):449-54.
-
2002: Argani Pedram; Antonescu Cristina R; Couturier Jérôme; Fournet Jean-Christophe; Sciot Raf; Debiec-Rychter Maria; Hutchinson Brian; Reuter Victor E; Boccon-Gibod Lilliane; Timmons Charles; Hafez Naiel; Ladanyi Marc
PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).
The American journal of surgical pathology 2002;26(12):1553-66.
-
2002: Allander Susanne V; Illei Peter B; Chen Yidong; Antonescu Cristina R; Bittner Mike; Ladanyi Marc; Meltzer Paul S
Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.
The American journal of pathology 2002;161(5):1587-95.
-
2002: Tickoo Satish K; Zee Sui Y; Obiekwe Sam; Xiao Hong; Koea Jonathan; Robiou Christian; Blumgart Leslie H; Jarnagin William; Ladanyi Marc; Klimstra David S
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
The American journal of surgical pathology 2002;26(8):989-97.
-
2002: Ladanyi Marc
EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights.
Cancer biology & therapy 2002;1(4):330-6.
-
2002: Colleoni Gisele W B; Capodieci Paola; Tickoo Satish; Cossman Jeffrey; Filippa Daniel A; Ladanyi Marc
Expression of SSX genes in the neoplastic cells of Hodgkin's lymphoma.
Human pathology 2002;33(5):496-502.
-
2002: Ladanyi Marc; Antonescu Cristina R; Drobnjak Marija; Baren Ann; Lui Man Yee; Golde David W; Cordon-Cardo Carlos
The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147.
The American journal of pathology 2002;160(4):1215-21.
-
2002: Antonescu Cristina R; Busam Klaus J; Iversen Kristin; Kolb Denise; Coplan Keren; Spagnoli Giulio C; Ladanyi Marc; Old Lloyd J; Jungbluth Achim A
MAGE antigen expression in monophasic and biphasic synovial sarcoma.
Human pathology 2002;33(2):225-9.
-
2002: Antonescu Cristina R; Tschernyavsky Sylvia J; Woodruff James M; Jungbluth Achim A; Brennan Murray F; Ladanyi Marc
Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
The Journal of molecular diagnostics : JMD 2002;4(1):44-52.
-
2002: Ladanyi Marc; Antonescu Cristina R; Leung Denis H; Woodruff James M; Kawai Akira; Healey John H; Brennan Murray F; Bridge Julia A; Neff James R; Barr Frederic G; Goldsmith Jeffrey D; Brooks John S J; Goldblum John R; Ali Syed Z; Shipley Janet; Cooper Colin S; Fisher Cyril; Skytting Björn; Larsson Olle
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Cancer research 2002;62(1):135-40.
-
2001: Karadimitris A; Li K; Notaro R; Araten D J; Nafa K; Thertulien R; Ladanyi M; Stevens A E; Rosenfeld C S; Roberts I A; Luzzatto L
Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH.
British journal of haematology 2001;115(4):1010-4.
-
2001: Antonescu C R; Tschernyavsky S J; Decuseara R; Leung D H; Woodruff J M; Brennan M F; Bridge J A; Neff J R; Goldblum J R; Ladanyi M
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3977-87.
-
2001: Jungbluth A A; Antonescu C R; Busam K J; Iversen K; Kolb D; Coplan K; Chen Y T; Stockert E; Ladanyi M; Old L J
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.
International journal of cancer. Journal international du cancer 2001;94(2):252-6.
-
2001: Ladanyi M
Fusions of the SYT and SSX genes in synovial sarcoma.
Oncogene 2001;20(40):5755-62.
-
2001: Mora J; Cheung N K; Juan G; Illei P; Cheung I; Akram M; Chi S; Ladanyi M; Cordon-Cardo C; Gerald W L
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.
Cancer research 2001;61(18):6892-8.
-
2001: Ladanyi M; Chan W C; Triche T J; Gerald W L
Expression profiling of human tumors: the end of surgical pathology?
The Journal of molecular diagnostics : JMD 2001;3(3):92-7.
-
2001: Bridge J A; Kanamori M; Ma Z; Pickering D; Hill D A; Lydiatt W; Lui M Y; Colleoni G W; Antonescu C R; Ladanyi M; Morris S W
Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.
The American journal of pathology 2001;159(2):411-5.
-
2001: Ladanyi M; Woodruff J M; Scheithauer B W; Bridge J A; Barr F G; Goldblum J R; Fisher C; Perez-Atayde A; Dal Cin P; Fletcher C D; Fletcher J A
Re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod pathol 2000;13:1336-46.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(7):733-7.
-
2001: Fletcher C D; Fletcher J A; Dal Cin P; Ladanyi M; Woodruff J M
Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?
Histopathology 2001;39(1):100-3.
-
2001: Argani P; Antonescu C R; Illei P B; Lui M Y; Timmons C F; Newbury R; Reuter V E; Garvin A J; Perez-Atayde A R; Fletcher J A; Beckwith J B; Bridge J A; Ladanyi M
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
The American journal of pathology 2001;159(1):179-92.
-
2001: Meyers P A; Krailo M D; Ladanyi M; Chan K W; Sailer S L; Dickman P S; Baker D L; Davis J H; Gerbing R B; Grovas A; Herzog C E; Lindsley K L; Liu-Mares W; Nachman J B; Sieger L; Wadman J; Gorlick R G
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2812-20.
-
2001: Khan J; Wei J S; Ringnér M; Saal L H; Ladanyi M; Westermann F; Berthold F; Schwab M; Antonescu C R; Peterson C; Meltzer P S
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks.
Nature medicine 2001;7(6):673-9.
-
2001: Chen B; Jhanwar S C; Ladanyi M
Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2001;10(2):100-4.
-
2001: Ladanyi M; Lui M Y; Antonescu C R; Krause-Boehm A; Meindl A; Argani P; Healey J H; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen P H; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Oncogene 2001;20(1):48-57.
-
2000: Colleoni G W; Jhanwar S C; Ladanyi M; Chen B
Comparison of a multiplex reverse transcriptase-polymerase chain reaction for BCR-ABL to fluorescence in situ hybridization, Southern blotting, and conventional cytogenetics in the monitoring of patients with Ph1-positive leukemias.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2000;9(4):203-9.
-
2000: Antonescu C R; Elahi A; Humphrey M; Lui M Y; Healey J H; Brennan M F; Woodruff J M; Jhanwar S C; Ladanyi M
Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.
The Journal of molecular diagnostics : JMD 2000;2(3):132-8.
-
2000: Wei G; Antonescu C R; de Alava E; Leung D; Huvos A G; Meyers P A; Healey J H; Ladanyi M
Prognostic impact of INK4A deletion in Ewing sarcoma.
Cancer 2000;89(4):793-9.
-
2000: de Alava E; Antonescu C R; Panizo A; Leung D; Meyers P A; Huvos A G; Pardo-Mindán F J; Healey J H; Ladanyi M
Prognostic impact of P53 status in Ewing sarcoma.
Cancer 2000;89(4):783-92.
-
2000: Argani P; Faria P A; Epstein J I; Reuter V E; Perlman E J; Beckwith J B; Ladanyi M
Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney.
The American journal of surgical pathology 2000;24(8):1087-96.
-
2000: Ladanyi M
Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms.
The American journal of pathology 2000;157(2):341-5.
-
2000: Antonescu C R; Elahi A; Healey J H; Brennan M F; Lui M Y; Lewis J; Jhanwar S C; Woodruff J M; Ladanyi M
Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2788-93.
-
2000: Ladanyi M; Bridge J A
Contribution of molecular genetic data to the classification of sarcomas.
Human pathology 2000;31(5):532-8.
-
2000: Antonescu C R; Kawai A; Leung D H; Lonardo F; Woodruff J M; Healey J H; Ladanyi M
Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2000;9(1):1-8.
-
2000: Gu M; Antonescu C R; Guiter G; Huvos A G; Ladanyi M; Zakowski M F
Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies.
The American journal of surgical pathology 2000;24(3):410-6.
-
2000: Antonescu C R; Leung D H; Dudas M; Ladanyi M; Brennan M; Woodruff J M; Cordon-Cardo C
Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.
The American journal of pathology 2000;156(3):977-83.
-
2000: de Alava E; Panizo A; Antonescu C R; Huvos A G; Pardo-Mindán F J; Barr F G; Ladanyi M
Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
The American journal of pathology 2000;156(3):849-55.
-
2000: Colleoni G W; Bridge J A; Garicochea B; Liu J; Filippa D A; Ladanyi M
ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
The American journal of pathology 2000;156(3):781-9.
-
2000: Shrimpton A; Lovell M A; Medeiros L J; Kaul K L; Ladanyi M; Voelkerding K V
1999 Association for Molecular Pathology annual meeting.
The Journal of molecular diagnostics : JMD 2000;2(1):53-5.
-
1999: Ladanyi M
Diagnosis and classification of small round-cell tumors of childhood.
The American journal of pathology 1999;155(6):2181-2.
-
1999: Kushner B H; LaQuaglia M P; Cheung N K; Kramer K; Hamelin A C; Gerald W L; Ladanyi M
Clinically critical impact of molecular genetic studies in pediatric solid tumors.
Medical and pediatric oncology 1999;33(6):530-5.
-
1999: Sreekantaiah C; Kwark E; Chuang L T; Ladanyi M
Cytogenetic and molecular characterization of a malignant mixed müllerian tumor of the uterus with a t(8;22)(q24.1;q12).
Cancer genetics and cytogenetics 1999;115(1):73-6.
-
1999: Guo W; Gorlick R; Ladanyi M; Meyers P A; Huvos A G; Bertino J R; Healey J H
Expression of bone morphogenetic proteins and receptors in sarcomas.
Clinical orthopaedics and related research 1999;(365):175-83.
-
1999: Ginsberg J P; de Alava E; Ladanyi M; Wexler L H; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder J S; Andrulis I L; Malik R; Sorensen P H; Womer R B; Barr F G
EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1809-14.
-
1999: Wolf A N; Ladanyi M; Paull G; Blaugrund J E; Westra W H
The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation.
Human pathology 1999;30(4):430-5.
-
1999: Lin P P; Brody R I; Hamelin A C; Bradner J E; Healey J H; Ladanyi M
Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Cancer research 1999;59(7):1428-32.
-
1999: Guo W; Healey J H; Meyers P A; Ladanyi M; Huvos A G; Bertino J R; Gorlick R
Mechanisms of methotrexate resistance in osteosarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):621-7.
-
1999: Gottesman S R; Haas D; Ladanyi M; Amorosi E L
Peripheral T cell lymphoma in a patient with common variable immunodeficiency disease: case report and literature review.
Leukemia & lymphoma 1999;32(5-6):589-95.
-
1999: Cole P; Ladanyi M; Gerald W L; Cheung N K; Kramer K; LaQuaglia M P; Kushner B H
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis.
Medical and pediatric oncology 1999;32(2):97-101.
-
1999: Wei G; Lonardo F; Ueda T; Kim T; Huvos A G; Healey J H; Ladanyi M
CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
International journal of cancer. Journal international du cancer 1999;80(2):199-204.
-
1998: Antonescu C R; Argani P; Erlandson R A; Healey J H; Ladanyi M; Huvos A G
Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
Cancer 1998;83(8):1504-21.
-
1998: Gerald W L; Ladanyi M; de Alava E; Cuatrecasas M; Kushner B H; LaQuaglia M P; Rosai J
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3028-36.
-
1998: Argani P; Perez-Ordoñez B; Xiao H; Caruana S M; Huvos A G; Ladanyi M
Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression.
The American journal of surgical pathology 1998;22(4):391-8.
-
1998: de Alava E; Kawai A; Healey J H; Fligman I; Meyers P A; Huvos A G; Gerald W L; Jhanwar S C; Argani P; Antonescu C R; Pardo-Mindan F J; Ginsberg J; Womer R; Lawlor E R; Wunder J; Andrulis I; Sorensen P H; Barr F G; Ladanyi M
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1248-55.
-
1998: Lawlor E R; Mathers J A; Bainbridge T; Horsman D E; Kawai A; Healey J H; Huvos A G; Bridge J A; Ladanyi M; Sorensen P H
Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1150-7.
-
1998: Antonescu C R; Gerald W L; Magid M S; Ladanyi M
Molecular variants of the EWS-WT1 gene fusion in desmoplastic small round cell tumor.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1998;7(1):24-8.
-
1998: Argani P; Zakowski M F; Klimstra D S; Rosai J; Ladanyi M
Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(1):65-71.
-
1998: Kawai A; Woodruff J; Healey J H; Brennan M F; Antonescu C R; Ladanyi M
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
The New England journal of medicine 1998;338(3):153-60.
-
1997: Lee S B; Kolquist K A; Nichols K; Englert C; Maheswaran S; Ladanyi M; Gerald W L; Haber D A
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.
Nature genetics 1997;17(3):309-13.
-
1997: Cheung N K; Kushner B H; LaQuaglia M P; Kramer K; Ambros P; Ambros I; Ladanyi M; Eddy J; Bonilla M A; Gerald W
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2117-20.
-
1997: Lonardo F; Ueda T; Huvos A G; Healey J; Ladanyi M
p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate.
Cancer 1997;79(8):1541-7.
-
1997: Brody R I; Ueda T; Hamelin A; Jhanwar S C; Bridge J A; Healey J H; Huvos A G; Gerald W L; Ladanyi M
Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.
The American journal of pathology 1997;150(3):1049-58.
-
1997: Ueda T; Healey J H; Huvos A G; Ladanyi M
Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone.
Sarcoma 1997;1(3-4):131-4.
-
1997: Ladanyi M
The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
Cancer surveys 1997;30():59-75.
-
1996: Ladanyi M; Gerald W L
Specificity of the EWS/WT1 gene fusion for desmoplastic small round cell tumour.
The Journal of pathology 1996;180(4):462.
-
1996: Parikh P M; Desai S; Naresh K N; Shakuntaka B; Laxminarayan K; Nair C N; Ladanyi M; Soman C S; Advani S H; Chaganti R S
Incidence of 5' bcl-2 rearrangement in patients with B cell chronic lymphocytic leukemia from India.
Leukemia research 1996;20(9):791-3.
-
1996: Ladanyi M; Cavalchire G
Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1996;5(3):154-8.
-
1996: Kushner B H; Cheung N K; LaQuaglia M P; Ambros P F; Ambros I M; Bonilla M A; Ladanyi M; Gerald W L
International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):2174-80.
-
1996: Filippa D A; Ladanyi M; Wollner N; Straus D J; O'Brien J P; Portlock C; Gangi M; Sun M
CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease.
Blood 1996;87(7):2905-17.
-
1996: Ladanyi M; Cavalchire G
Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
Genes, chromosomes & cancer 1996;15(3):173-7.
-
1996: Lacerda J F; Ladanyi M; Louie D C; Fernandez J M; Papadopoulos E B; O'Reilly R J
Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
The Journal of experimental medicine 1996;183(3):1215-28.
-
1996: Kushner B H; Cheung N K; LaQuaglia M P; Ambros P F; Ambros I M; Bonilla M A; Gerald W L; Ladanyi M; Gilbert F; Rosenfield N S; Yeh S D
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):373-81.
-
1996: Lacerda J F; Ladanyi M; Jagiello C; O'Reilly R J
Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice.
Transplantation 1996;61(3):492-7.
-
1996: Tison V; Cerasoli S; Morigi F; Ladanyi M; Gerald W L; Rosai J
Intracranial desmoplastic small-cell tumor. Report of a case.
The American journal of surgical pathology 1996;20(1):112-7.
-
1995: Fligman I; Lonardo F; Jhanwar S C; Gerald W L; Woodruff J; Ladanyi M
Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.
The American journal of pathology 1995;147(6):1592-9.
-
1995: de Alava E; Ladanyi M; Rosai J; Gerald W L
Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay.
The American journal of pathology 1995;147(6):1584-91.
-
1995: Ladanyi M
The emerging molecular genetics of sarcoma translocations.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1995;4(3):162-73.
-
1995: Michaeli J; Niesvizky R; Siegel D; Ladanyi M; Lieberman P H; Filippa D A
Proteinaceous (angiocentric sclerosing) lymphadenopathy: a polyclonal systemic, nonamyloid deposition disorder.
Blood 1995;86(3):1159-62.
-
1995: Downing J R; Ladanyi M; Raffeld M; Weiss L M; Morris S W
Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease.
Lancet 1995;345(8954):918; author reply 920-1.
-
1995: Gerald W L; Rosai J; Ladanyi M
Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(4):1028-32.
-
1995: Ladanyi M; Lewis R; Jhanwar S C; Gerald W; Huvos A G; Healey J H
MDM2 and CDK4 gene amplification in Ewing's sarcoma.
The Journal of pathology 1995;175(2):211-7.
-
1995: Green I; Espiritu E; Ladanyi M; Chaponda R; Wieczorek R; Gallo L; Feiner H
Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1995;8(1):39-45.
-
1994: Shivnarain D; Ladanyi M; Zakowski M F
Detection of BCL2 rearrangement in archival cytological smears of B-cell lymphomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(9):915-9.
-
1994: Ladanyi M; Cavalchire G; Morris S W; Downing J; Filippa D A
Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease.
The American journal of pathology 1994;145(6):1296-300.
-
1994: Sreekantaiah C; Ladanyi M; Rodriguez E; Chaganti R S
Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.
The American journal of pathology 1994;144(6):1121-34.
-
1994: Ladanyi M; Gerald W
Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.
Cancer research 1994;54(11):2837-40.
-
1994: Papadopoulos E B; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi M H; Castro-Malaspina H; Childs B H; Gillio A P; Small T N
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
The New England journal of medicine 1994;330(17):1185-91.
-
1994: Tallini G; Ladanyi M; Rosai J; Jhanwar S C
Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors.
Cytogenetics and cell genetics 1994;66(4):253-9.
-
1993: Ladanyi M; Park C K; Lewis R; Jhanwar S C; Healey J H; Huvos A G
Sporadic amplification of the MYC gene in human osteosarcomas.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1993;2(3):163-7.
-
1993: Ladanyi M; Lewis R; Garin-Chesa P; Rettig W J; Huvos A G; Healey J H; Jhanwar S C
EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1993;2(3):141-6.
-
1993: Bradley J F; Rothberg P G; Ladanyi M; Chaganti R S
Hypermutation of the MYC gene in diffuse large cell lymphomas with translocations involving band 8q24.
Genes, chromosomes & cancer 1993;7(3):128-30.
-
1993: Ladanyi M; Cha C; Lewis R; Jhanwar S C; Huvos A G; Healey J H
MDM2 gene amplification in metastatic osteosarcoma.
Cancer research 1993;53(1):16-8.
-
1992: Murty V V; Ladanyi M; Houldsworth J; Mikraki V; Chaganti R S
Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1992;1(4):221-8.
-
1992: Ladanyi M; Wang S; Niesvizky R; Feiner H; Michaeli J
Proto-oncogene analysis in multiple myeloma.
The American journal of pathology 1992;141(4):949-53.
-
1992: Ladanyi M; Offit K; Parsa N Z; Condon M R; Chekka N; Murphy J P; Filippa D A; Jhanwar S C; Dalla-Favera R; Chaganti R S
Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas.
Blood 1992;79(8):2124-30.
-
1992: Ladanyi M; Offit K; Chaganti R S
Variant t(8;14) translocations in non-Burkitt's non-Hodgkin's lymphomas.
Blood 1992;79(5):1377-9.
-
1992: Ladanyi M; Wang S
Detection of rearrangements of the BCL2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1992;1(1):31-5.
-
1991: Ladanyi M
Bcl-2 gene rearrangement in salivary gland lymphoma.
The American journal of surgical pathology 1991;15(8):814.
-
1991: Ladanyi M; Parsa N Z; Offit K; Wachtel M S; Filippa D A; Jhanwar S C
Clonal cytogenetic abnormalities in Hodgkin's disease.
Genes, chromosomes & cancer 1991;3(4):294-9.
-
1991: Offit K; Jhanwar S C; Ladanyi M; Filippa D A; Chaganti R S
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.
Genes, chromosomes & cancer 1991;3(3):189-201.
-
1991: Mikraki V; Ladanyi M; Chaganti R S
Structural alterations in the 5' region of the BCL2 gene in follicular lymphomas with BCL2-MBR or BCL2-MCR rearrangements.
Genes, chromosomes & cancer 1991;3(2):117-21.
-
1991: Ladanyi M; Offit K; Jhanwar S C; Filippa D A; Chaganti R S
MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas.
Blood 1991;77(5):1057-63.
-
1990: Houldsworth J; Cordon-Cardo C; Ladanyi M; Kelsen D P; Chaganti R S
Gene amplification in gastric and esophageal adenocarcinomas.
Cancer research 1990;50(19):6417-22.
-
1990: Rodriguez E; Rao P H; Ladanyi M; Altorki N; Albino A P; Kelsen D P; Jhanwar S C; Chaganti R S
11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas.
Cancer research 1990;50(19):6410-6.
-
1990: Offit K; Ladanyi M; Gangi M D; Ebrahim S A; Filippa D; Chaganti R S
Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(9):625-30.
-
1990: Ebrahim S A; Ladanyi M; Desai S B; Offit K; Jhanwar S C; Filippa D A; Lieberman P H; Chaganti R S
Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas.
Genes, chromosomes & cancer 1990;2(1):27-35.
-
1990: Samaniego F; Rodriguez E; Houldsworth J; Murty V V; Ladanyi M; Lele K P; Chen Q G; Dmitrovsky E; Geller N L; Reuter V
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification.
Genes, chromosomes & cancer 1990;1(4):289-300.
-
1990: Ladanyi M; Samaniego F; Reuter V E; Motzer R J; Jhanwar S C; Bosl G J; Chaganti R S
Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors.
Journal of the National Cancer Institute 1990;82(3):221-7.
-
1989: Ladanyi M; Traganos F; Huvos A G
Benign metastasizing giant cell tumors of bone. A DNA flow cytometric study.
Cancer 1989;64(7):1521-6.
-
1989: Chaganti R S; Ladanyi M; Samaniego F; Offit K; Reuter V E; Jhanwar S C; Bosl G J
Leukemic differentiation of a mediastinal germ cell tumor.
Genes, chromosomes & cancer 1989;1(1):83-7.
-
1988: Ladanyi M; Roy I;
Mediastinal germ cell tumors and histiocytosis.
Human pathology 1988;19(5):586-90.
-
1987: Ladanyi M; Fraser R S
Pulmonary involvement in giant cell arteritis.
Archives of pathology & laboratory medicine 1987;111(12):1178-80.
-
1987: Ladanyi M; Mulay S; Arseneau J; Bettez P
Estrogen and progesterone receptor determination in the papillary cystic neoplasm of the pancreas. With immunohistochemical and ultrastructural observations.
Cancer 1987;60(7):1604-11.
-
1985: Ladanyi M; Dubrovsky B
CNV and time estimation.
The International journal of neuroscience 1985;26(3-4):253-7.
-
1984: Ladanyi M
Residual sentience and cognitive death: ethical issues in brain death and the persistent vegetative state.
Canadian Medical Association journal 1984;131(6):632, 634-6.
Sign-in to see more